Company intelligence
Mittal Consulting
Premium Medical Device Consulting Business | Regulatory and Reimbursement
About Mittal Consulting
Mittal Consulting is a premium boutique regulatory and reimbursement consulting firm supporting innovative medical device startups and growth-stage manufacturers. We help MedTech companies develop clear, practical strategies across FDA regulatory pathways, planning, market access, reimbursement, and commercialization. Our team works as an extension of our clients, helping reduce risk, accelerate development, and bring complex medical technologies to market with confidence. Our regulatory services include: • FDA regulatory strategy • Pre-Submissions (Q-Submissions) • 510(k) submissions • De Novo requests • Premarket Approval applications • Investigational Device Exemptions • Breakthrough Device and STeP designation requests • FDA meeting preparation and representation • Regulatory VC due diligence and gap assessments Our reimbursement and market access services include: • Reimbursement strategy • Coding and coverage assessments • DME and HCPCS pathway support • Evidence planning • Payer and commercialization strategy We support medical devices across: • Cardiovascular and structural heart • Neurotechnology and neuromodulation • Orthopedics • Surgical, Ophthalmology and robotic devices • Digital health, AI, and SaMD • Wearables and remote monitoring • Diagnostics and IVD • Women’s health • Rehabilitation and home-use devices
Verified activity
Signals from Mittal Consulting
4 published signals
People
Mittal Consulting welcomed Isabella Ott, MS, to the team to help grow the brand, strengthen content and messaging, and connect with medtech innovators.
Reported by Mittal Consulting
Presence & Recognition
Mittal Consulting is hosting the Nucleate Genesis Speaker Series hosted by Center For Entrepreneurial Innovation (CEI) Arizona to talk about FDA regulatory strategy.
Reported by Kristen Mittal, RAC, PMP
Presence & Recognition
Mittal Consulting hosted a successful FDA meeting in D.C. with Don Vaughn, Jonathan Downar, and the Ampa team.
Reported by Kristen Mittal, RAC, PMP
Customers & Market
Mittal Consulting supported Ampa Health through their FDA submission.
Reported by Mittal Consulting